Federal Register Notice: FDA is making an amendment to the 5/21 notice of meeting of the Science Board to the FDA to add the following to the agenda portion: The Science Board 6/14 will hear about and review the scientific validity of the agency’s “Interim Melamine and Analogs Safety/Risk Assessment.” To view this notice, click here.
